Third Arc Bio is a biotech company developing multifunctional antibodies that generate immune synapses that precisely activate or inhibit T cells. The company’s drug development engine delivers superior biologics optimized to create best-in-class T cell engagement by leveraging two technologies that power a pipeline of high value therapeutics – a solid tumor synergy platform and an I&I platform that offers a novel approach to precision immune regulation at a tissue-specific level to achieve superior efficacy and safety. To learn more, visit www.thirdarcbio.com.
Company Details
- Employees
- 33
- Address
- Philadelphia, Pennsylvania 19002, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://thirdarcbio.com/
- Keywords
- Spring House.
- HQ
- Philadelphia, Pennsylvania
Third Arc Bio Questions
Third Arc Bio's website is https://thirdarcbio.com/
Third Arc Bio's LinkedIn profile is https://www.linkedin.com/company/third-arc-bio
Third Arc Bio has
33 employees.
View email and phone details for 33
employees at Third Arc Bio.
Third Arc Bio's industry is
Biotechnology Research
Third Arc Bio's top competitors are
Omega Funds,
Arrivent Biopharma,
Interius Biotherapeutics,
Madrigal Pharmaceuticals,
Carisma Therapeutics,
Scorpion Therapeutics,
Uniquity Bio,
Immunovant,
Spring House Innovation Park,
Igm Biosciences, Inc..
Third Arc Bio's categories are Biotechnology Research
